Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients (Q63572414)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients |
clinical trial |
Statements
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Activecontrolled Study Comparing Sustained Benefit of Two Treatment Paradigms (Erenumab qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients (English)
0 references
20 May 2019
0 references
4 December 2020
0 references
600
0 references
18 year
0 references